基于CT的新模型预测局部晚期食管鳞癌对新辅助PD-1阻断联合化疗的病理完全缓解
研究纳入117例局部晚期食管鳞癌患者(训练队列82例、验证队列35例),基于新辅助PD-1阻断联合化疗前及两周期后CT的定量与定性特征建立逻辑回归模型预测病理完全缓解。模型在训练队列AUC为0.876,验证队列Kappa值为0.796。
要点
- 基于治疗前CT的肿瘤与正常食管壁CT衰减差、治疗后肿瘤强化增幅及肿瘤体积构建模型。
- 模型预测病理完全缓解的AUC为0.876,优于各单一独立预测因子。
- 验证队列Kappa值为0.796,提示模型预测与病理结果一致性良好。
核心结论
- 该新型模型可可靠预测局部晚期食管鳞癌对新辅助PD-1阻断联合化疗的病理完全缓解。
研究设计与样本
- 连续纳入117例局部晚期食管鳞癌患者,分为训练队列82例和验证队列35例;所有患者在新辅助PD-1阻断联合化疗前及两周期后食管切除术前分别行非增强和增强胸腹部CT;采用单因素分析和二元逻辑回归分析确定病理完全缓解的独立预测因子,以受试者工作特征曲线分析评估模型性能,并在验证队列中以Kappa检验验证。
诊断标准与关键数值
- 训练队列中,治疗前CT所获肿瘤与背景正常食管壁CT衰减差(ΔTNpre)、治疗后CT图像所获肿瘤增强扫描后CT衰减增幅(ΔTpost)和治疗前CT所获肿瘤大体体积(GTV)为病理完全缓解的独立预测因子,比值比分别为1.128(95%CI:0.997-1.277)、1.113(95%CI:0.965-1.239)和1.133(95%CI:1.043-1.231),P值均<0.05;逻辑回归模型方程为0.121×ΔTNpre+0.107×ΔTpost+0.125×GTV-9.856,预测病理完全缓解的受试者工作特征曲线下面积为0.876,优于各独立预测因子;验证队列Kappa值为0.796。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop a novel CT-based model to predict pathological complete response (pCR) of locally advanced esophageal squamous cell carcinoma (ESCC) to neoadjuvant PD-1 blockade in combination with chemotherapy.
METHODS: 117 consecutive patients with locally advanced ESCC were stratified into training cohort (n = 82) and validation cohort (n = 35). All patients underwent non-contrast and contrast-enhanced thoracic and upper abdominal CT before neoadjuvant PD-1 blockade in combination with chemotherapy (CTpre), and after two cycles of the therapy before esophagectomy (CTpost), respectively. Univariate analyses and binary logistic regression analyses of ESCC quantitative and qualitative CT features were performed to determine independent predictors of pCR. Prediction performance of the model developed with independent predictors from training cohort was evaluated by receiver operating characteristic (ROC) analysis, and validated by Kappa test in validation cohort.
RESULTS: In training cohort, the difference in CT attenuation between tumor and background normal esophageal wall obtained from CTpre (ΔTNpre), tumoral increased CT attenuation after contrast-enhanced scan from CTpost images (ΔTpost) and gross tumor volume (GTV) from CTpre were independent predictors of pCR (odds ratio = 1.128 (95% confidence interval (CI): 0.997-1.277), 1.113 (95%CI: 0.965-1.239) and 1.133 (95%CI: 1.043-1.231), respectively, all P-values < 0.05). Logistic regression model equation (0.121 × ΔTNpre + 0.107 × ΔTpost + 0.125 × GTV - 9.856) to predict pCR showed the best performance with an area under the ROC of 0.876, compared with each independent predictor. The good performance was confirmed by the Kappa test (K-value = 0.796) in validation cohort.
CONCLUSIONS: This novel model can be reliable to predict pCR to neoadjuvant PD-1 blockade in combination with chemotherapy in locally advanced ESCC.
引用
- Zhou HY, Guo WW, Ou J, et al. A CT-based novel model to predict pathological complete response of locally advanced esophageal squamous cell carcinoma to neoadjuvant PD-1 blockade in combination with chemotherapy. Eur J Radiol. 2023. PMID: 37651827. doi:10.1016/j.ejrad.2023.111065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。